Articles written by: Helen Turner

bluebird bio Inc. (BLUE)’s Financial Results Comparing With Zafgen Inc. (NASDAQ:ZFGN).

bluebird bio Inc. (NASDAQ:BLUE) and Zafgen Inc. (NASDAQ:ZFGN), both competing one another are Biotechnology companies. We will contrast their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio bluebird bio Inc. 39.50M 179.93 523.83M -8.19 […]

Reviewing Gran Tierra Energy Inc. (GTE)’s and Zion Oil & Gas Inc. (NASDAQ:ZN)’s results.

Both Gran Tierra Energy Inc. (NYSEAMERICAN:GTE) and Zion Oil & Gas Inc. (NASDAQ:ZN) are Independent Oil & Gas companies, competing one another. We will compare their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Contrasting of Zynerba Pharmaceuticals Inc. (ZYNE) and Sesen Bio Inc. (NASDAQ:SESN).

Both Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) and Sesen Bio Inc. (NASDAQ:SESN) are Biotechnology companies, competing one another. We will compare their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynerba Pharmaceuticals Inc. N/A 0.00 40.24M […]

Waters Corporation (WAT) and Merit Medical Systems Inc. (NASDAQ:MMSI) Comparison side by side.

As Medical Instruments & Supplies companies, Waters Corporation (NYSE:WAT) and Merit Medical Systems Inc. (NASDAQ:MMSI) are our subject to contrast. And more specifically their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters Corporation […]

Xenetic Biosciences Inc. (XBIO)’s Financial Results Comparing With Achillion Pharmaceuticals Inc. (NASDAQ:ACHN).

As Biotechnology companies, Xenetic Biosciences Inc. (NASDAQ:XBIO) and Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) are our subject to contrast. And more specifically their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Xenetic Biosciences Inc. 7.50M 2.55 […]

Reviewing TriNet Group Inc. (TNET)’s and WEX Inc. (NYSE:WEX)’s results.

We are contrasting TriNet Group Inc. (NYSE:TNET) and WEX Inc. (NYSE:WEX) on their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. They both are Business Services companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TriNet Group Inc. 3.43B […]

Reviewing Keane Group Inc. (FRAC)’s and Profire Energy Inc. (NASDAQ:PFIE)’s results.

As Oil & Gas Equipment & Services companies, Keane Group Inc. (NYSE:FRAC) and Profire Energy Inc. (NASDAQ:PFIE) are our subject to compare. And more specifically their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Platinum Eagle Acquisition Corp. (EAGL) and GTY Technology Holdings Inc. (NASDAQ:GTYH) Contrasting side by side.

As Conglomerates companies, Platinum Eagle Acquisition Corp. (NASDAQ:EAGL) and GTY Technology Holdings Inc. (NASDAQ:GTYH) are our subject to contrast. And more specifically their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Platinum Eagle Acquisition […]

Reviewing BioXcel Therapeutics Inc. (BTAI)’s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)’s results.

We are contrasting BioXcel Therapeutics Inc. (NASDAQ:BTAI) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) on their risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership. They both are Biotechnology companies, competing one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioXcel Therapeutics Inc. […]

CTI BioPharma Corp. (CTIC) and Spero Therapeutics Inc. (NASDAQ:SPRO) Comparing side by side.

We are contrasting CTI BioPharma Corp. (NASDAQ:CTIC) and Spero Therapeutics Inc. (NASDAQ:SPRO) on their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CTI BioPharma Corp. 12.28M […]